MedTrace Logo

Prospective Randomized Study Comparing Renal Artery Stenting (RESIST)With/Without Distal Protection

NCT00234585 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-12-10

No results posted yet for this study

Summary

This study is designed to demonstrate the safety and efficacy of using a protective device/drug to prevent renal injury during renal artery stenting and to assess whether the preventative effects are measurable and if there is a differential treatment effect for either device alone or in combination.

Conditions

  • Renal Artery Stenosis

Interventions

DEVICE

Renal Artery Stent with Protective Device/Drug

Sponsors & Collaborators

  • Centocor, Inc.

    collaborator INDUSTRY

  • Johnson & Johnson

    collaborator INDUSTRY

  • University of Toledo Health Science Campus

    lead OTHER

Principal Investigators

  • Christopher Cooper, M.D. · Medical University of Ohio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00234585 on ClinicalTrials.gov